Published in Aust N Z J Psychiatry on February 01, 2006
Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab (2007) 3.30
Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab (2007) 2.46
Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res (2005) 1.66
Remission in schizophrenia: critical and systematic review. Harv Rev Psychiatry (2012) 1.51
Switching from brand-name to generic psychotropic medications: a literature review. CNS Neurosci Ther (2010) 1.11
A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Eur Neuropsychopharmacol (2004) 1.01
Hypomania induced by adjunctive lamotrigine. Am J Psychiatry (2003) 1.01
Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment? J Psychopharmacol (2012) 0.92
Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia. J Clin Psychiatry (2002) 0.87
Gabapentin in the treatment of antipsychotic-induced akathisia in schizophrenia. Int Clin Psychopharmacol (2005) 0.84
Seizures, coma, and coagulopathy following olanzapine overdose. Can J Psychiatry (2005) 0.84
Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia: a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use. Can J Psychiatry (2004) 0.81
Diabetes insipidus secondary to combination atypical antipsychotic and lithium use in a bipolar disorder patient: a case report. Prim Care Companion CNS Disord (2011) 0.80
Topiramate-induced weight loss in schizophrenia: a retrospective case series study. Can J Clin Pharmacol (2007) 0.79
Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine. J Clin Psychopharmacol (2011) 0.79
Aripiprazole-Induced Hypoprolactinemia in an Adult Male with First-Episode Psychosis. Clin Schizophr Relat Psychoses (2015) 0.78
Tardive dyskinesia associated with olanzapine in a neuroleptic-naive patient with schizophrenia. Can J Psychiatry (2004) 0.78
Gabapentin-induced paradoxical exacerbation of psychosis in a patient with schizophrenia. Can J Psychiatry (2002) 0.78
Alternative pharmacotherapy for trichotillomania: a report of successful bupropion use. J Clin Psychiatry (2004) 0.77
Migraine headache prophylaxis and treatment with low-dose mirtazapine. Int Clin Psychopharmacol (2003) 0.77
Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. Can J Clin Pharmacol (2006) 0.76
Late-onset agranulocytosis in a patient with schizophrenia after 17 months of clozapine treatment. J Clin Psychopharmacol (2003) 0.76
Long-term lamotrigine adjunctive to antipsychotic monotherapy in schizophrenia: further evidence. Can J Psychiatry (2004) 0.75
Clozapine for first-episode schizophrenia. Am J Psychiatry (2002) 0.75
Possible association of syndrome of inappropriate secretion of antidiuretic hormone with St John's wort use. J Clin Psychopharmacol (2014) 0.75
Donepezil-associated mania in two patients who were using donepezil without a prescription. J Clin Psychopharmacol (2014) 0.75
Fungal dermatitis with olanzapine in schizophrenia. Can J Psychiatry (2003) 0.75
Using the rating scale for psychotic symptoms to characterize delusions expressed in a schizophrenia patient with "Internet psychosis". Can J Psychiatry (2002) 0.75
Obsessive-compulsive symptoms in schizophrenia induced by risperidone and responding to fluoxetine. Can J Psychiatry (2003) 0.75
First- and second-generation antipsychotics. Can J Psychiatry (2010) 0.75
Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine. Pharmacotherapy (2004) 0.75